Open Access Open Access  Restricted Access Subscription Access

Development and Validation of UV Spectrophotometric Method for Quantitative Estimation of Clobetasol 17-Propionate


Affiliations
  • Guru Jambheshwar University of Science and Technology, Department of Pharmaceutical Sciences, Hisar, India
  • Guru Jambheshwar University of Science and Technology, Department of Pharmaceutical Sciences, hisar, India
  • Maharishi Dayanand University, Department of Pharmaceutical Sciences, Rohtak, India
 

Clobetasol 17-propionate is used most potent topical glucocorticoid clinical effective in treatment of topical dermatitis, vitiligo and psoriasis. A rapid, simple, selective and precise UV- Visible Spectrophotometric method has been developed for the determination of Clobetasol 17-Propionate (CP) in bulk forms and dosage formulations. The spectrophotometric detection was carried out at an absorption maximum of 239 nm using ethanol as solvent. The method was validated for specificity, linearity, accuracy, precision, and robustness. The detector response for the CP was linear over the selected concentration range 2 to 40μg/ml with a correlation coefficient of 0.9999. The accuracy was between 99.1 and 101.4 %. The precision of 4μg/ml sample preparation three times in a day (intraday) was 0.1325%. The Limit of Detection (LOD) and Limit of Quantification (LOQ) are 0.84 and 2.55μg/ml, respectively. The recovery of CP was about 101.84%. The results demonstrated that the excipients in the commercial formulation did not interfere with the method and can be conveniently employed for daily routine quality control analysis of CP in bulk drug, marketed formulations.

Keywords

Clobetasol 17-Propionate, ICH Guidelines, UV-Visible Spectroscopy, Validation
User
Notifications
Font Size

  • Franz TJ, Lehman PA, Feldman SR, Spellman MC. Bioavailability of clobetasol propionate in different vehicles. Skin Pharmacol Appl Skin Physiol. 2003; 16:212–6.
  • Wendt H, Frosch PJ. Clinico-pharmacological models for the assay of topical corticoids. Switzerland: Karger AG; 1982.
  • Sparkes CG, Wilson L. The clinical evaluation of a new topical corticosteroid, clobetasol propionate. Brit J Dermatol. 1974; 90:197–203.
  • Floden CH, Woodbridge P, Samman P, Kurwa AR. Comparison of the response of psoriasis, over a 6-month period, to clobetasol propionate and fluocinolone acetonide ointments. Curr Med Res Opin. 1975; 3:375–81.
  • Christophers E, Schopf E, Kligman AM, Stoughton, RB. Topical corticosteroid therapy: A novel approach to safer drugs. New York: Raven Press Ltd; 1988.
  • Fontana MC, Bastos MO, Beck RCR. Development and validation of a fast RP-HPLC method for the determination of clobetasol propionate in topical nanocapsule suspensions. J Chromatogr Sci. 2010; 48:637–40.
  • Modi P, Vairale A. Cleaning Method: A validated HPLC method for determination of clobetasol propionate resi- dues on the surface of manufacturing equipment. International Journal of Analytical and Bioanalytical Chemistry. 2012; 2:133–8.
  • Patel AG, Patel RB, Patel MR. Liquid chromatographic determination of clobetasol-17-butyrate in ointment. J Assoc off Anal Chem. 1990; 73:893–5.
  • Sparidans RW, Velsen GA, de Roos MP, Schellens JHM, Carla AFM, Koomen B, Beijnen JH. Liquid chromatography- tendem mass spectrometric assay for clobetasol propionate in human serum from patients with acute dermitis. J Chromatogr B. 2010; 878:2150–4.
  • Musmade PB, Deshpande PB, Dengle SJ, Talole KB, Pathak SM, Adiga MNS, Bhat K, Udupa N, Bairy KL. High performance liquid chromatographic method for determination of clobetasol in rat plasma and its application to skin penetration. J Bioanal Biomed. 2010; 2:1–7.
  • Fauzee AFB, Walker RB. Forced degradation studies of clobetasol 17-propionate in methanol, propylene glycol, as bulk drug and cream formulations by RP-HPLC. J Sep Sci. 2013; 36:849–56.
  • Jakasaniya MA, Shah JS, Maheswari DG. Simultaneous estimation of clobetasol propionate and fusidic acid in cream dosage form by reversed phase high performance liquid chromatographic method. Pharmacophore. 2014; 5:231–8.
  • Malani PS, Raj HA, Jain VC. Development and validation of analytical method for simultaneous estimation of miconazole nitrate and clobetasol propionate in cream by HPTLC method. Pharma Science Monitor. 2014; 5:386–99.
  • Badilli U, Amasya G, zkan SO, Tarimci N. Simultaneous determination of clobetasol propionate and calcipotriol in a novel fixed dose emulgel formulation by LC-UV. Chromatograhia. 2013; 76:133–40.
  • Marika K, Katherine F, Jianmin L, Mike CG, Debra F. A sensitive high-throughput hplc assay for simultaneous determination of everolimus and clobetasol propionate. J Chromatogr Sci. 2008; 46:23–9.
  • Turabi ZM, Khatatbeh OA. Simultaneous determination of clobetasol propionate and chlorocresol in cream by stability indicating RP-HPLC method. Int J Pharm Sci Drug Res. 2014; 6:140–4.
  • Ahuja S, Scypinsk S. Handbook of modern pharmaceutical analysis. London: Academic Press; 2001.
  • ICH Guideline Q2 (R1). Validation of analytical procedures: Text and methodology. 2005 Nov.
  • Validation of analytical procedure: Text and methodology. Proceeding of International Conference on Harmonization (ICH); Geneva. 2005.
  • Behera S, Ghanty S, Ahmad F, Santra S, Banerjee, S. UV-visible spectrophotometric method development and validation of assay of paracetamol tablet formulation. J Anal Bioanal Techniques. 2012; 3(6).
  • Debnath SK, Saisivam S, Dash DK, Debnath M. Development and validation of UV-spectrophotometric methods for quantitative estimation of prothionamide in pure and pharmaceutical dosage forms. Int Curr Pharm J. 2015; 4:402–4.
  • Kadam PV, Bhingare CL, Nikam RY, Pawar, SA. Development and validation of UV spectrophotometric method for the estimation of curcumin in cream formulation. Pharmaceutical Methods. 2013; 4:43–5.
  • Kashyap R, Subrahmanyam EVS, Sharbaraya AR. Development and validation of UV spectroscopy method for the estimation of prednisolone in bulk and dosage form. J Chem Pharm Res. 2012; 4:1090–6.

Abstract Views: 813

PDF Views: 248




  • Development and Validation of UV Spectrophotometric Method for Quantitative Estimation of Clobetasol 17-Propionate

Abstract Views: 813  |  PDF Views: 248

Authors

Neelam Devi
, India
Sunil Kumar
, India
Sunny Rajan
, India
Jagbir Gegoria
, India
Sheefali Mahant
, India
Rekha Rao
, India

Abstract


Clobetasol 17-propionate is used most potent topical glucocorticoid clinical effective in treatment of topical dermatitis, vitiligo and psoriasis. A rapid, simple, selective and precise UV- Visible Spectrophotometric method has been developed for the determination of Clobetasol 17-Propionate (CP) in bulk forms and dosage formulations. The spectrophotometric detection was carried out at an absorption maximum of 239 nm using ethanol as solvent. The method was validated for specificity, linearity, accuracy, precision, and robustness. The detector response for the CP was linear over the selected concentration range 2 to 40μg/ml with a correlation coefficient of 0.9999. The accuracy was between 99.1 and 101.4 %. The precision of 4μg/ml sample preparation three times in a day (intraday) was 0.1325%. The Limit of Detection (LOD) and Limit of Quantification (LOQ) are 0.84 and 2.55μg/ml, respectively. The recovery of CP was about 101.84%. The results demonstrated that the excipients in the commercial formulation did not interfere with the method and can be conveniently employed for daily routine quality control analysis of CP in bulk drug, marketed formulations.

Keywords


Clobetasol 17-Propionate, ICH Guidelines, UV-Visible Spectroscopy, Validation

References